| Net Cash Provided by (Used in) Operating Activities |
-1.84B |
USD |
+3.83% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
1.36B |
USD |
-36.7% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4.5B |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q2 2024 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-471M |
USD |
-290% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
691M |
USD |
+24.5% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
294M |
USD |
+85.8% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
0 |
shares |
|
Q2 2024 |
Q3 2025 |
| Additional Paid in Capital |
19.3B |
USD |
+49.6% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
958M |
USD |
+36.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q2 2024 |
Q3 2025 |